Topical Drug Bioavailability, Bioequivalence, and Penetration
Other Authors: | , |
---|---|
Format: | eBook |
Language: | English |
Published: |
New York, NY
Springer US
1993, 1993
|
Edition: | 1st ed. 1993 |
Subjects: | |
Online Access: | |
Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
Table of Contents:
- A Medical Rationale
- 3 Prodrugs and Their Topical Use
- 4 Ultrasound-Mediated Transdermal Drug Delivery
- II In Vitro Methodology
- 5 Practical Considerations in Developing a Quality Control (In Vitro Release) Procedure for Topical Drug Products
- 6 Diffusion Cell Design
- III In Vivo Methodology
- 7 Cutaneous Bioavailability, Bioequivalence, and Percutaneous Absorption: In Vivo Methods, Problems, and Pitfalls
- 8 The Human Skin Blanching Assay for Topical Corticosteroid Bioavailability Assessment
- 9 Predictive Approaches I: The Stripping Technique
- 10 Predictive Approaches II: Mass-Balance Procedure
- 11 In Vivo Topical Bioavailability and Skin Decontamination: Example Alachlor
- 12 Grafted Skin and Skin Flaps
- IV Factors Influencing Percutaneous Transport
- 13 In Vivo and In Vitro Skin Uptake and Permeation Studies: Critical Considerations and Factors Which Affect Them
- 14 V